| Phase 2/3 |
| NCT04708054 |
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With… |
Acute Myeloid Leukemia |
Recruiting |
| NCT02205762 |
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With… |
Langerhans Cell Histiocytosis |
Active, Not Recruiting |
| Phase 2 |
| NCT01515527 |
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With… |
Leukemia |
Recruiting |
| NCT06504459 |
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine… |
Acute Monocytic Leukemia |
Recruiting |
| NCT07032727 |
Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated… |
Targeted Therapy |
Recruiting |
| NCT02115295 |
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute… |
Acute Biphenotypic Leukemia |
Recruiting |
| NCT03589729 |
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in… |
Acute Myeloid Leukemia |
Recruiting |
| NCT06561360 |
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People… |
Hairy Cell Leukemia |
Recruiting |
| NCT05365035 |
A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax… |
Myelodysplastic Syndromes |
Recruiting |
| NCT03586609 |
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With… |
Acute Myeloid Leukemia |
Recruiting |
| NCT00412594 |
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia |
Hairy Cell Leukemia |
Recruiting |
| NCT02250937 |
Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor… |
Acute Myeloid Leukemia |
Active, Not Recruiting |
| NCT04195945 |
CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade… |
Acute Myeloid Leukemia |
Active, Not Recruiting |
| Phase 1/2 |
| NCT06561152 |
Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML |
Refractory Acute Myeloid Leukemia |
Recruiting |
| NCT04797767 |
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid… |
Acute Biphenotypic Leukemia |
Recruiting |
| NCT06965114 |
Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients… |
Hairy Cell Leukemia |
Recruiting |
| NCT07311746 |
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With… |
T-cell Prolymphocytic Leukemia |
Not Yet Recruiting |
| Phase 1 |
| NCT04375631 |
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell… |
Recurrent Acute Myeloid Leukemia |
Recruiting |
| Not specified |
| NCT05797740 |
Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA) |
Multiple Sclerosis |
Active, Not Recruiting |